How about instead of presenting dribble (eg one US based investor)
......please somebody else do some real research and present it here.
No better something to research and take your efforts to the chatline - with more detail on this particular abstract, from the Spain conference.
---------------------------------------------------------------------------------------------------
(OC08) Alternative uses for PI 3-kinase inhibitors outside cancer
Peter Shepherd - University of Auckland and Maurice Wilikins Centre, New Zealand
Over the years we have seen how a PI3K /mTOR drug might improve cancer treatment, for a particular cancer indication. Here are dozens of research papers - all in the one conference, which purports to maybe change much of cancer treatment - yet Kazia are not even at the conference.
